Recursion Pharmaceuticals, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
41 S Rio Grande Street, Salt Lake City, Utah

Insiders trading volume in the past year

Recursion Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lux Ventures IV, L.P. Former 10% Owner $138M Dec 7, 2021
Investment Co PJSC Mubadala 10%+ Owner $137M Mar 2, 2023
Blake Borgeson Director $44.6M -$3.18M -6.65% Sep 3, 2024
Zachary Bogue Director, 10%+ Owner $39.5M Jul 3, 2023
Dean Y. Li Director $23M -$396K -1.69% Jul 1, 2024
MIC Capital Partners (Public) Parallel Cayman, LP 10%+ Owner $14.7M Nov 1, 2021
Michael Secora Chief Financial Officer $9.05M -$4.11M -31.2% Aug 15, 2024
Christopher Gibson Chief Executive Officer, Director $4.68M -$7.73M -62.3% Sep 4, 2024
Najat Khan Chief R&D Commercial Officer, Director $4.04M Aug 1, 2024
Tina Marriott President and COO $3.94M -$620K -13.6% Aug 29, 2024
David J. Mauro Chief Medical Officer $1.54M Aug 15, 2024
Shafique Virani Chief Business Officer $1.45M -$756K -34.3% Jan 16, 2024
Ramona Doyle Chief Medical Officer $1.28M May 16, 2022
Zavain Dar Director $750K -$181K -19.5% Jul 1, 2024
Chavez R. Martin Director $530K Apr 1, 2024
Terry-Ann Burrell Director $514K Jul 1, 2024
Robert Hershberg Director $454K Jun 3, 2024
Mic Capital Partners (Public) (Us) Im, Llc Other* Nov 1, 2021

Recent Insider Transactions by Companies or Individuals for Recursion Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.